KL and gastric cancer: Here, we adapted a workflow to systematically identify all Kla modifications at the proteomic scale in malignant and adjacent tissues of patients in a prospectively collected GI cancer cohort, including liver, pancreatic, colorectal, and gastric cancer samples.